Guggenheim Capital LLC Inogen Inc Transaction History

Guggenheim Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$63.19 - $95.15 $203,092 - $305,812	-3,214 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$90.12 - $152.23 $22,530 - $38,057	250 Added 8.43%	3,214 $307,000
Q4 2018 Feb 14, 2019	SELL	$112.83 - $239.74 $266,730 - $566,745	-2,364 Reduced 44.37%	2,964 $368,000
Q3 2018 Nov 14, 2018	BUY	$189.1 - $282.92 $327,899 - $490,583	1,734 Added 48.25%	5,328 $1.3 Million
Q2 2018 Aug 14, 2018	SELL	$123.8 - $192.48 $1.59 Million - $2.48 Million	-12,874 Reduced 78.18%	3,594 $669,000
Q1 2018 May 15, 2018	BUY	$114.22 - $133.22 $5,025 - $5,861	44 Added 0.27%	16,468 $2.02 Million
Q4 2017 Feb 14, 2018	BUY	$93.4 - $128.74 $1.3 Million - $1.8 Million	13,950 Added 563.86%	16,424 $1.96 Million
Q3 2017 Nov 14, 2017	BUY	$91.08 - $104.49 $225,331 - $258,508	2,474	2,474 $236,000

143

21M

119K

149K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $214M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.